Constellation Pharmaceuticals Inc (CNST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||
| Net Income | -13,663 | -34,533 |
| Depreciation Amortization | 215 | 203 |
| Accounts payable and accrued liabilities | -1,006 | N/A |
| Other Working Capital | -2,568 | 591 |
| Other Operating Activity | -2,890 | 964 |
| Operating Cash Flow | $-19,912 | $-32,775 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -322 | -945 |
| Investing Cash Flow | $-322 | $-945 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -3,254 | N/A |
| Common Stock Issued | 52 | N/A |
| Other Financing Activity | 0 | 19,105 |
| Financing Cash Flow | $-3,202 | $19,105 |
| Beginning Cash Position | 37,162 | 51,777 |
| End Cash Position | 13,726 | 37,162 |
| Net Cash Flow | $-23,436 | $-14,615 |
| Free Cash Flow | ||
| Operating Cash Flow | -19,912 | -32,775 |
| Capital Expenditure | -322 | N/A |
| Free Cash Flow | -20,234 | -32,775 |